Novoxel

Skin Rejuvenation Technology

Health Tech & Life Sciences
Active
Mature Netanya, Israel Founded 2011
Last updated 2026-06-18
Total raised
Stage
Mature
Founded
2011
Headcount
30
HQ
Netanya, Israel
Sector
Health Tech & Life Sciences

About

Novoxel has developed a fractional, microtip aesthetic technology for thermomechanical ablation (TMA). TMA is a platform for the development of lightweight, miniaturized, and cost-effective products. The companys Tixel technology allows precise, accurate, and painless tissue evaporation without undesired thermal damage to surrounding healthy tissue. Tixel is a non-laser fractional treatment technology that can transfer thermal energy to the skin quickly and safely. Its treatments are safe, with short healing times. Tixel is versatile, covering the treatment spectrum of both superficial and deep ablative lasers, and can also be set to nonablative mode in order to transfer heat to the dermis while sparing the epidermis. Novoxels Mezotix technology transfers pure heat to the skin quickly and safely through very brief contact. The thermal effect induces renewal of epidermal cells and regeneration of collagen in the dermis.

Q&A

What is Novoxel's primary focus?
Novoxel specializes in Skin Rejuvenation Technology, developing fractional, microtip aesthetic technology for thermomechanical ablation (TMA).
When was Novoxel founded?
Novoxel was founded in August 2011.
Where is Novoxel headquartered?
Novoxel is headquartered in Netanya, Center District, Israel.
What is Novoxel's Tixel technology?
Novoxel's Tixel technology is a non-laser fractional treatment that transfers thermal energy to the skin for precise, accurate, and painless tissue evaporation without undesired thermal damage.
What is Novoxel's Mezotix technology?
Novoxel's Mezotix technology transfers pure heat to the skin through brief contact, inducing renewal of epidermal cells and regeneration of collagen in the dermis.
Who are the co-founders of Novoxel?
The co-founders of Novoxel are Michael Slatkine and Jacob Zlochover.
In which sector does Novoxel primarily operate?
Novoxel's primary sector is Health Tech & Life Sciences, specifically within Medical Devices and Medical Treatment & Therapeutics.

Team · 2

Founder · Co-founder
Founder · Co-founder
LinkedIn ↗

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesMedical DevicesMedical Treatment & Therapeutics
Target customers
Healthcare & Life SciencesHealthcareProviders
Business model
B2B

Highlights

Verified

Tags

patent-pendingskin-caredermatologyclinicsmedical-devicespain-freetissue-regenerationhealthcare-providersmobile-applications
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)